# Digital Twins for Oncology Clinical Trials

*Patient-specific virtual replicas for treatment simulation and clinical decision support (January 2026)*

**Version**: 1.0.0
**Status**: Active Development
**Last Updated**: February 2026

---

## Executive Summary

Digital twins (DTs) in oncology create dynamic virtual replicas of patients, enabling clinicians to simulate disease progression and treatment responses. This directory provides production-ready tools for integrating digital twin technology into physical AI oncology clinical trials.

**Key Capabilities**:
- Patient-specific tumor modeling from imaging data
- Treatment response simulation (chemotherapy, radiation, immunotherapy)
- In-silico clinical trial optimization
- Real-time intraoperative guidance
- Real-time DT synchronization with live clinical data streams
- Multi-organ toxicity prediction and dose modification guidance
- Adaptive radiation therapy with dose accumulation on deforming anatomy
- Tumor microenvironment modeling for immunotherapy response prediction
- Virtual trial cohort generation with Bayesian adaptive designs
- FDA-grade validation and verification with model card generation

---

## Market Context

| Metric | Value | Source |
|--------|-------|--------|
| Healthcare DT Market (2024) | $902.59M | Grand View Research |
| Projected CAGR (2025-2030) | 25.9% | Grand View Research |
| Projected Market (2028) | $21.1B | Industry projections |
| Clinical Trial Participation | <10% | NCI Statistics |
| Oncology Drug Approval Rate | 5.1% | FDA Data |

---

## Directory Structure

```
digital-twins/
├── README.md                      # This file
│
├── patient-modeling/              # Patient-specific DT creation
│   ├── README.md                  # Modeling overview
│   └── tumor_twin_pipeline.py     # TumorTwin integration
│
├── treatment-simulation/          # Treatment response prediction
│   ├── README.md                  # Simulation overview
│   └── treatment_simulator.py     # Multi-modality treatment sim
│
├── clinical-integration/          # Clinical workflow integration
│   ├── README.md                  # Integration overview
│   └── clinical_dt_interface.py   # Hospital system integration
│
└── examples-twins/                # Advanced DT engineering examples
    ├── README.md                  # Examples documentation
    ├── 01_realtime_dt_synchronization.py        # EKF/particle filter sync
    ├── 02_multi_organ_toxicity_twin.py          # PBPK multi-organ toxicity
    ├── 03_adaptive_radiation_therapy_dt.py       # Deformable registration + dose
    ├── 04_tumor_microenvironment_immunotherapy_dt.py  # TME + checkpoint inhibitor
    ├── 05_virtual_trial_cohort_dt.py            # In-silico trial design
    └── 06_dt_validation_verification.py         # FDA V&V + model cards
```

---

## Framework Dependencies

| Framework | Version | Purpose | Source |
|-----------|---------|---------|--------|
| TumorTwin | 1.0.0 | Patient-specific tumor DTs | [GitHub](https://github.com/OncologyModelingGroup/TumorTwin) |
| NVIDIA Omniverse | 2025.1+ | Physics simulation platform | [NVIDIA](https://www.nvidia.com/en-us/omniverse/) |
| NVIDIA Clara | 2025+ | Medical imaging AI | [NVIDIA](https://www.nvidia.com/en-us/clara/) |
| MONAI | 1.4.0+ | Medical imaging framework | [GitHub](https://github.com/Project-MONAI/MONAI) |
| FEniCS | 2019.1+ | Finite element simulations | [FEniCS](https://fenicsproject.org/) |
| Isaac Sim | 5.0.0+ | Robotic DT simulation | [NVIDIA](https://docs.isaacsim.omniverse.nvidia.com/) |

---

## Quick Start

### 1. Patient-Specific Tumor Digital Twin

```python
from digital_twins.patient_modeling import TumorTwinPipeline
from monai.transforms import LoadImage

# Initialize pipeline with TumorTwin framework
pipeline = TumorTwinPipeline(
    model_type="reaction_diffusion",
    solver="gpu_parallel"
)

# Load patient imaging data
ct_scan = LoadImage()("patient_001_ct.nii.gz")
mri_scan = LoadImage()("patient_001_mri_t1.nii.gz")

# Create patient-specific digital twin
patient_dt = pipeline.create_twin(
    patient_id="ONCO-2026-001",
    imaging_data={"ct": ct_scan, "mri": mri_scan},
    tumor_segmentation="patient_001_tumor_mask.nii.gz",
    clinical_data={
        "age": 62,
        "tumor_grade": "III",
        "molecular_markers": {"EGFR": "positive", "KRAS": "wild_type"}
    }
)

# Calibrate model to longitudinal data
patient_dt.calibrate(
    longitudinal_scans=["scan_week_0.nii.gz", "scan_week_4.nii.gz"],
    treatment_history=[{"drug": "cisplatin", "dose_mg": 75, "day": 0}]
)

print(f"Tumor volume: {patient_dt.current_volume_cm3:.2f} cm^3")
print(f"Growth rate: {patient_dt.proliferation_rate:.4f} /day")
```

### 2. Treatment Response Simulation

```python
from digital_twins.treatment_simulation import TreatmentSimulator

simulator = TreatmentSimulator(patient_twin=patient_dt)

# Define treatment protocols
chemotherapy = {
    "type": "chemotherapy",
    "drug": "paclitaxel",
    "dose_mg_m2": 175,
    "schedule": "every_3_weeks",
    "cycles": 6
}

radiation = {
    "type": "radiation",
    "total_dose_gy": 60,
    "fractions": 30,
    "technique": "IMRT"
}

# Simulate treatment response
chemo_response = simulator.predict_response(
    treatment=chemotherapy,
    horizon_days=180
)

radiation_response = simulator.predict_response(
    treatment=radiation,
    horizon_days=90
)

# Compare treatment outcomes
print(f"Chemo predicted tumor reduction: {chemo_response.volume_change_percent:.1f}%")
print(f"Radiation predicted tumor reduction: {radiation_response.volume_change_percent:.1f}%")
```

### 3. In-Silico Clinical Trial Simulation

```python
from digital_twins.clinical_integration import InSilicoTrialSimulator

# Create virtual patient cohort
trial_sim = InSilicoTrialSimulator(
    n_virtual_patients=1000,
    tumor_type="non_small_cell_lung_cancer",
    stage_distribution={"IIIA": 0.4, "IIIB": 0.35, "IV": 0.25}
)

# Define trial arms
control_arm = {"drug": "standard_chemo", "dose": "standard"}
experimental_arm = {"drug": "novel_immunotherapy", "dose": "escalating"}

# Run in-silico trial
results = trial_sim.run_trial(
    control=control_arm,
    experimental=experimental_arm,
    primary_endpoint="progression_free_survival",
    duration_months=24
)

print(f"Predicted PFS improvement: {results.hazard_ratio:.2f}")
print(f"Statistical power: {results.power:.1%}")
print(f"Recommended sample size: {results.optimal_n}")
```

---

## Oncology Digital Twin Applications

### 1. Tumor Growth Modeling

**Mathematical Models Supported**:

| Model Type | Equation | Use Case |
|------------|----------|----------|
| Logistic Growth | dN/dt = rN(1-N/K) | Solid tumors |
| Gompertz | dN/dt = aN·ln(K/N) | Growth saturation |
| Reaction-Diffusion | ∂u/∂t = D∇²u + ρu(1-u) | Glioblastoma invasion |
| Mechanistic | Multi-scale ABM | Tumor microenvironment |

**TumorTwin Integration**:

```python
# TumorTwin reaction-diffusion model for glioblastoma
from tumortwin import ReactionDiffusionModel, PatientData

# Load patient data structure
patient = PatientData.from_dicom(
    t1_path="T1_pre.dcm",
    t1ce_path="T1CE_pre.dcm",
    t2_path="T2_pre.dcm",
    flair_path="FLAIR_pre.dcm"
)

# Initialize model with MRI-derived parameters
model = ReactionDiffusionModel(
    diffusion_coefficient=0.1,  # mm^2/day (white matter)
    proliferation_rate=0.05,    # /day
    carrying_capacity=1.0
)

# Calibrate to patient-specific data
model.calibrate(
    patient_data=patient,
    longitudinal_timepoints=[0, 30, 60],  # days
    optimization_method="bayesian"
)

# Predict tumor evolution
prediction = model.predict(horizon_days=180, output_interval=7)
```

### 2. Treatment Response Prediction

**Supported Treatment Modalities**:

| Modality | Digital Twin Capability |
|----------|------------------------|
| Chemotherapy | Drug pharmacokinetics, tumor cell kill modeling |
| Radiation | Dose distribution, LQ model response |
| Immunotherapy | Immune cell dynamics, checkpoint inhibition |
| Targeted Therapy | Pathway-specific response modeling |
| Surgery | Resection margin optimization, recurrence risk |

### 3. Robotic Surgery Digital Twins

**Integration with Physical AI**:

```python
from digital_twins.clinical_integration import SurgicalDigitalTwin
from unification.simulation_physics import IsaacMuJoCoBridge

# Create surgical digital twin from patient imaging
surgical_dt = SurgicalDigitalTwin.from_imaging(
    ct_scan="patient_ct.nii.gz",
    organ_segmentation="organ_labels.nii.gz",
    tumor_mask="tumor_mask.nii.gz"
)

# Export to simulation frameworks
bridge = IsaacMuJoCoBridge()

# Generate Isaac Sim scene for robot training
isaac_scene = surgical_dt.export_to_isaac(
    robot_model="dvrk_psm",
    include_soft_tissue=True,
    deformation_model="fem"
)

# Generate MuJoCo model for physics validation
mujoco_model = surgical_dt.export_to_mujoco(
    include_contact_dynamics=True,
    tissue_stiffness_kpa=5.0
)

# Validate physics equivalence
validation = bridge.validate_equivalence(
    isaac_scene, mujoco_model,
    test_trajectories=["approach", "grasp", "retract"]
)
```

---

## Clinical Workflow Integration

### DICOM/FHIR Integration

```python
from digital_twins.clinical_integration import ClinicalConnector

# Connect to hospital PACS/EHR
connector = ClinicalConnector(
    pacs_endpoint="https://hospital.pacs.local",
    fhir_endpoint="https://hospital.fhir.local/R4",
    credentials_path="/secure/credentials.json"
)

# Query patient imaging studies
studies = connector.query_imaging(
    patient_id="MRN-123456",
    modality=["CT", "MR"],
    body_part="CHEST",
    date_range=("2025-01-01", "2026-01-31")
)

# Create digital twin from clinical data
patient_dt = connector.create_digital_twin(
    patient_id="MRN-123456",
    imaging_studies=studies,
    include_clinical_notes=True,
    include_lab_results=True
)

# Generate treatment recommendations
recommendations = patient_dt.generate_recommendations(
    treatment_options=["surgery", "chemoradiation", "immunotherapy"],
    optimization_target="quality_adjusted_life_years"
)
```

---

## Regulatory Considerations

### FDA Guidance Compliance

| Requirement | Implementation |
|-------------|----------------|
| 21 CFR Part 11 | Audit trails, electronic signatures |
| AI/ML Device Guidance (Jan 2025) | Model documentation, validation |
| PCCP Guidance (Aug 2025) | Predetermined change control |
| IEC 62304 | Software development lifecycle |

### Validation Requirements

```python
from digital_twins.validation import DTValidator

validator = DTValidator(regulatory_framework="FDA_21CFR11")

# Validate digital twin against clinical outcomes
validation_report = validator.validate(
    digital_twin=patient_dt,
    clinical_outcomes="outcomes_database.csv",
    metrics=["prediction_accuracy", "calibration", "discrimination"],
    confidence_level=0.95
)

# Generate regulatory documentation
validator.generate_documentation(
    output_path="regulatory_docs/",
    include_audit_trail=True,
    include_model_card=True
)
```

---

## References

### Digital Twin Frameworks
- [TumorTwin](https://github.com/OncologyModelingGroup/TumorTwin) - Patient-specific cancer DTs (UT Austin, arXiv:2505.00670)
- [NVIDIA Omniverse](https://www.nvidia.com/en-us/omniverse/) - Physical AI simulation platform
- [NVIDIA Clara](https://www.nvidia.com/en-us/clara/) - Healthcare AI platform

### Research Publications
- [Digital twins in healthcare: comprehensive review](https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2025.1633539/full) - Frontiers, 2025
- [Enhancing clinical trials with digital twins](https://www.nature.com/articles/s41540-025-00592-0) - npj Systems Biology, 2025
- [Application of digital twins for personalized oncology](https://www.nature.com/articles/s41568-025-00850-7) - Nature Reviews Cancer, 2025
- [Digital twins for stratification of breast cancer patients](https://cancer.jmir.org/2025/1/e64000) - JMIR Cancer, 2025

### Industry Applications
- [Sanofi-QuantHealth AI clinical trial simulation](https://www.healthcareittoday.com/2025/11/03/sanofi-and-quanthealth-team-up-to-advance-ai-powered-digital-twins-and-clinical-trial-simulation/) - QuantHealth partnership
- [Johnson & Johnson MedTech surgical robotics](https://www.massdevice.com/johnson-johnson-medtechsurgical-robotics-nvidia-ai/) - NVIDIA AI integration, 2026 launch

---

*This directory is part of the Physical AI Oncology Trials Unification Framework.*
